Search

everythinglearnresearchcommunity

for

Search:↓

Lymphoid-specific helicase (Lsh) is crucial for skin growth, change, and healing after injury.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Lysine carboxymethyl cysteinate (LCC) protects skin from UVB damage by activating autophagy.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Hair follicles help skin immune recovery after UVB exposure.

Isolated limb perfusion is a safe and effective treatment for limb melanoma.

Tph cells are linked to the severity of systemic lupus erythematosus.

SKO-derived SKP-like cells may help with hair regeneration and skin restoration.

Mice with alopecia areata had wider lymphatic vessels in their skin.

Lymphocytes may hinder hair stem cells, causing hair loss without scarring.

A wearable cap-like device using light therapy reduced scalp skin lesions by 71% and was painless.

Feline cutaneous lymphocytosis is likely reactive, while canine cutaneous lymphocytosis needs more study to understand its nature.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Chemotherapy for leukemia led to full hair regrowth in a child with alopecia totalis.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.